4basebio PLC (FRA:88Q)
Germany · Delayed Price · Currency is EUR 6.15
0.00 (0.00%)
At close: Jan 30, 2026
4basebio Market Cap
4basebio has a market cap or net worth of €102.77 million as of January 30, 2026. Its market cap has decreased by -44.84% in one year.
Market Cap
102.77M
Enterprise Value
90.44M
Revenue
2.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.15
Market Cap Chart
Since February 17, 2021, 4basebio's market cap has increased from 47.83M to 102.77M, an increase of 114.85%. That is a compound annual growth rate of 16.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 102.77M | -5.82% |
| Dec 31, 2025 | 109.11M | -41.76% |
| Dec 31, 2024 | 187.36M | 94.08% |
| Dec 29, 2023 | 96.54M | -2.09% |
| Dec 30, 2022 | 98.60M | 9.32% |
| Dec 31, 2021 | 90.19M | 88.56% |
| Feb 17, 2021 | 47.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 54.72B |
| Siemens Healthineers AG | 46.92B |
| Bayer Aktiengesellschaft | 43.24B |
| Fresenius SE & Co. KGaA | 26.29B |
| MEDICLIN Aktiengesellschaft | 184.30M |
| Heidelberg Pharma AG | 130.52M |
| LIMES Schlosskliniken AG | 126.60M |
| FamiCord AG | 91.52M |